跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-ACAMPROSATE acamprosate calcium 333 mg enteric coated tablets blister - TGA Drug Approval Details
Approvals
/
TGA
/
APO-ACAMPROSATE acamprosate calcium 333 mg enteric coated tablets blister
Approved
STANDARD
APO-ACAMPROSATE acamprosate calcium 333 mg enteric coated tablets blister
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
07488f52c5007f64
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
07488f52c5007f64
Product Name
APO-ACAMPROSATE acamprosate calcium 333 mg enteric coated tablets blister
Artg Id
286652
Artg Name
APO-ACAMPROSATE acamprosate calcium 333 mg enteric coated tablets blister
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
2017-12-21
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/0485e66979dacb48635f3a69ee376bdd.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/694a3dd91513f4333f5cafee2c4ce197.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
07488f52c5007f64
Type
Standard
Back to TGA Approvals